Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
about
Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analoguesBinding of 3,4,5,6-Tetrahydroxyazepanes to the Acid-β-glucosidase Active Site: Implications for Pharmacological Chaperone Design for Gaucher DiseaseNeuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds.Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.Glucocerebrosidase inhibitors for the treatment of Gaucher disease.sp2-Iminosugar O-, S-, and N-glycosides as conformational mimics of α-linked disaccharides; implications for glycosidase inhibition.Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.Design and Synthesis of Potent Quinazolines as Selective β-Glucocerebrosidase ModulatorsNew Directions in Gaucher Disease.Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease.Structural basis of pharmacological chaperoning for human β-galactosidase.A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier.
P2860
Q27667205-4CF2DA35-1A69-4F07-9C63-F2824D37A7EBQ27675348-463EB141-E91E-4EA5-A00D-2A9FDC85CD6FQ34464236-1B2900E0-7A8E-4695-BFFB-EDD9B7B62B16Q35686212-026C25A4-793D-4A4C-9E4F-D246E8557BA4Q38097869-1A49A036-7288-4B7B-AF0A-F0D3C7D980A7Q38324679-5D703A2E-9DC3-4DD3-B101-DACF5F42C16DQ38797648-D6456D13-5140-4BEF-B4A6-E9FE0DE1F6D8Q38824056-DA613266-17B3-4B4B-A944-E692F8700B34Q38905996-118AE172-764A-47E1-8B04-B28CE6BB2687Q39162679-8346EB16-7049-49F9-9B74-BF47CE76D69BQ39885525-0355D2E2-B05B-4721-9ACF-0D8D1277C7F7Q41574484-4207E29C-50B9-4446-B653-8E9B7E0AADC9Q51750678-3DBAC608-6265-460F-A89F-6C451C10304C
P2860
Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@ast
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@en
type
label
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@ast
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@en
prefLabel
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@ast
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@en
P2093
P2860
P356
P1476
Bicyclic (galacto)nojirimycin ...... towards β-glucocerebrosidase.
@en
P2093
Amadeu Llebaria
Ana Trapero
Carmen Ortiz Mellet
José M García Fernández
M Isabel García-Moreno
Matilde Aguilar-Moncayo
Meritxell Egido-Gabás
P2860
P304
P356
10.1039/C1OB05234A
P577
2011-03-30T00:00:00Z